16-1352142-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_032520.5(GNPTG):​c.93G>C​(p.Glu31Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,581,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E31K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00095 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000087 ( 0 hom. )

Consequence

GNPTG
NM_032520.5 missense

Scores

3
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.211

Publications

1 publications found
Variant links:
Genes affected
GNPTG (HGNC:23026): (N-acetylglucosamine-1-phosphate transferase subunit gamma) This gene encodes the gamma sunbunit of the N-acetylglucosamine-1-phosphotransferase complex. This hexameric complex, composed of alpha, beta and gamma subunits, catalyzes the first step in synthesis of a mannose 6-phosphate lysosomal recognition marker. This enzyme complex is necessary for targeting of lysosomal hydrolases to the lysosome. Mutations in the gene encoding the gamma subunit have been associated with mucolipidosis IIIC, also known as mucolipidosis III gamma.[provided by RefSeq, Feb 2010]
GNPTG Gene-Disease associations (from GenCC):
  • GNPTG-mucolipidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011537433).
BP6
Variant 16-1352142-G-C is Benign according to our data. Variant chr16-1352142-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 550374.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000945 (144/152314) while in subpopulation AFR AF = 0.00332 (138/41580). AF 95% confidence interval is 0.00287. There are 0 homozygotes in GnomAd4. There are 73 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032520.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNPTG
NM_032520.5
MANE Select
c.93G>Cp.Glu31Asp
missense
Exon 2 of 11NP_115909.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GNPTG
ENST00000204679.9
TSL:1 MANE Select
c.93G>Cp.Glu31Asp
missense
Exon 2 of 11ENSP00000204679.4
GNPTG
ENST00000529110.2
TSL:2
c.177G>Cp.Glu59Asp
missense
Exon 1 of 10ENSP00000435349.2
GNPTG
ENST00000683887.1
c.93G>Cp.Glu31Asp
missense
Exon 2 of 11ENSP00000506886.1

Frequencies

GnomAD3 genomes
AF:
0.000946
AC:
144
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00333
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000151
AC:
29
AN:
192460
AF XY:
0.000124
show subpopulations
Gnomad AFR exome
AF:
0.00262
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000867
AC:
124
AN:
1429626
Hom.:
0
Cov.:
32
AF XY:
0.0000889
AC XY:
63
AN XY:
708328
show subpopulations
African (AFR)
AF:
0.00288
AC:
95
AN:
32952
American (AMR)
AF:
0.000126
AC:
5
AN:
39700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25536
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38070
South Asian (SAS)
AF:
0.0000122
AC:
1
AN:
82050
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49366
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5158
European-Non Finnish (NFE)
AF:
0.0000109
AC:
12
AN:
1097696
Other (OTH)
AF:
0.000186
AC:
11
AN:
59098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000945
AC:
144
AN:
152314
Hom.:
0
Cov.:
32
AF XY:
0.000980
AC XY:
73
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00332
AC:
138
AN:
41580
American (AMR)
AF:
0.000392
AC:
6
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000291
Hom.:
0
Bravo
AF:
0.00107
ESP6500AA
AF:
0.00259
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000154
AC:
18

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

GNPTG-mucolipidosis Uncertain:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 19, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

not provided Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.017
Eigen_PC
Benign
-0.044
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.89
D
M_CAP
Pathogenic
0.69
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
0.21
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.5
N
REVEL
Uncertain
0.48
Sift
Uncertain
0.014
D
Sift4G
Uncertain
0.028
D
Polyphen
0.97
D
Vest4
0.31
MutPred
0.33
Loss of sheet (P = 0.0357)
MVP
0.96
MPC
0.020
ClinPred
0.12
T
GERP RS
0.84
PromoterAI
-0.0086
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.26
gMVP
0.60
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8052503; hg19: chr16-1402143; API